StockData
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc. (NERV) stock

NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$2.16−0.04 (-1.82%)

Close on Nov 17, 2026Market cap $103.14MP/E –Yield –

Minerva Neurosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Minerva Neurosciences's price to book ratio was 2.7× on Apr 29, 2022, against 1.9× a year earlier. Over the last 5 years it ranged from 1.2× to 12.6×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 20222.7×+1.5
2021Dec 31, 20211.2×−0.5
2020Dec 31, 20201.7×−3.3
2019Dec 31, 20195.0×+2.4
2018Dec 31, 20182.6×+0.8
2017Dec 29, 20171.8×−1.8
2016Dec 30, 20163.6×+1.2
2015Dec 31, 20152.4×+0.4
2014Dec 31, 20142.0×–

More Minerva Neurosciences figures

See a number that looks wrong?